Typhoid Vi Polysaccharide Vaccine Global Market Report 2025

Global Typhoid Vi Polysaccharide Vaccine Market Report 2024

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025 – By Type( Child, Adult ), By Route of Administration( Oral, Parenteral ), By Application( Government Institution, Private Sector, Other Applications ) – Market Size, Trends, And Global Forecast 2025-2034

Name: Typhoid Vi Polysaccharide Vaccine Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Typhoid Vi Polysaccharide Vaccine Global Market Report 2025

Proud Members Of

Typhoid Vi Polysaccharide Vaccine Market Definition

Typhoid VI polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi.

The main types of typhoid VI polysaccharide vaccine are child and adult. A child is a person between birth and puberty, or full growth. The routes of administration for this vaccine include oral and parenteral and are applied in government institutions, the private sector, and others.

Typhoid Vi Polysaccharide Vaccine Market Segmentation

The typhoid vi polysaccharide vaccine market covered in this report is segmented –

1) By Type: Child, Adult

2) By Route Of Administration: Oral, Parenteral

3) By Application: Government Institution, Private Sector, Other Applications

Subsegments:

1) By Child: Pediatric Formulations, Age-Specific Dosages

2) By Adult: Standard Adult Formulations, High-Risk Population Formulations

Typhoid Vi Polysaccharide Vaccine Market Size and growth rate 2025 to 2029: Graph

Typhoid Vi Polysaccharide Vaccine Market Size 2025 And Growth Rate

The typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from $5.78 billion in 2024 to $6.77 billion in 2025 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to disease prevalence, global health initiatives, traveler vaccination, government immunization efforts, vaccine efficacy and safety.

Typhoid Vi Polysaccharide Vaccine Market Growth Forecast

The typhoid vi polysaccharide vaccine market size is expected to see rapid growth in the next few years. It will grow to $13.36 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to expanded immunization programs, global health policy focus, epidemiological surveillance, rising demand in travel medicine, environmental and social factors. Major trends in the forecast period include R&D investments, regulatory support, epidemiological studies, public health awareness.

Book your 30 minutes free consultation with our research experts

Typhoid VI Polysaccharide Vaccine Market Driver: Escalating Typhoid Prevalence Fuels Expansion In The Typhoid Vi Polysaccharide Vaccine Market

Rising typhoid prevalence is expected to propel the growth of the typhoid VI polysaccharide vaccine market going forward. Typhoid is an infection caused by the bacteria Salmonella typhi that can be fatal. It usually spreads through contaminated food or drink. Typhoid Vi polysaccharide vaccine is used to immunize adults and children aged 2 and up against typhoid fever caused by Salmonella enterica serovar Typhi, S. Typhi. For instance, in August 2024, according to the data published by the UK Health Security Agency, a UK-based government agency, laboratory-confirmed symptomatic cases of enteric fever in England, Wales, and Northern Ireland increased from 2021 to 2022, with S. Typhi rising from 108 to 313, S. Paratyphi A from 31 to 135, and S. Paratyphi B from 13 to 18. Therefore, the rising typhoid prevalence is driving the growth of the typhoid Vi polysaccharide vaccine market.

Typhoid VI Polysaccharide Vaccine Market Driver: Strategic Impact Of Growing Immunization Campaigns On The Typhoid Vi Polysaccharide Vaccine Market

Growing immunization campaigns is expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Immunization campaigns refer to delivery strategy used to quickly reach large numbers of individuals with one or more vaccines, typically conducted at the national or sub-national level. Immunization campaigns are essential for the effective deployment and utilization of the typhoid Vi Polysaccharide Vaccine, especially in regions where typhoid fever poses a significant public health challenge. For instance, in April 2022, with support from Gavi, the Vaccine Alliance, a public–private global health partnership, World Health Organization, a Switzerland-based intergovernmental organization, United Nations International Children's Emergency Fund, a US-based Humanitarian aid organization and other partners, the Government of Nepal launched a new vaccine campaign introducing Typhoid Conjugate Vaccine (TCV) into the routine immunization program across the country. The 3-week campaign, which will run from 8th April to 1st May 2022, aims to reach all children between 15 months and 15 years to quickly achieve wider protection from typhoid, increase the impact of the vaccine introduction and combat the rise of antimicrobial resistance. Over 50,000 vaccination sites have been established across rural and urban settings in the country, including schools. Therefore, growing immunization campaigns is driving the growth of the typhoid Vi polysaccharide vaccine market.

Typhoid VI Polysaccharide Vaccine Market Driver: Healthcare Expenditure Surge Fuels Growth In The Typhoid VI Polysaccharide Vaccine Market

Growing expenditure in the healthcare sector is expected to propel the growth of the typhoid Vi polysaccharide vaccine market going forward. Healthcare expenditure refers to the overall cost of health care (including public and private expenditures) as a percentage of GDP. Rising healthcare expenditure helps typhoid Vi polysaccharide vaccine manufacturers develop more typhoid vaccines, which increase the demand for the typhoid Vi polysaccharide vaccine market. For instance, in September 2024, according to the statistics published by Cross River Therapy, a US-based provider of ABA therapy services, the U.S. pharmaceutical industry generated $550 billion in revenue, with Americans spending $576.9 billion on medicine in 2021, and projected spending is expected to increase to $605-$635 billion by 2025. Therefore, growing expenditure in the healthcare sector is driving the growth of the typhoid Vi polysaccharide vaccine market.

Global Typhoid VI Polysaccharide Vaccine Market Major Players

Major companies operating in the typhoid vi polysaccharide vaccine market are Sanofi S.A., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited

Global Typhoid VI Polysaccharide Vaccine Market Trend: International Vaccine Institute's Dynamic Partnerships With Moderna And GSK Fuel Advances In Typhoid Vi Polysaccharide Vaccine Market

Strategic partnerships are a key trend gaining popularity in the typhoid Vi polysaccharide vaccine market. Major companies operating in the typhoid Vi polysaccharide vaccine market are entering into partnerships to strengthen their position in the typhoid Vi polysaccharide market. For instance, in July 2022, The International Vaccine Institute, a South Korea-based international organization focused on infectious diseases of global health importance such as cholera, typhoid, shigella, and salmonella, partnered with Moderna, a US-based biopharmaceutical company. This partnership LED to the world’s first affordable oral cholera vaccine and a new-generation typhoid conjugate vaccine.

Global Typhoid VI Polysaccharide Vaccine Market Trend: Innovative Collaborations And Strategic Investments In Typhoid Vi Polysaccharide Vaccine Development

Major companies operating in the typhoid Vi polysaccharide vaccine market are focusing on investments to sustain their position in the market. Investments in the development and distribution of the typhoid Vi polysaccharide vaccine have been substantial, reflecting the importance of preventing and controlling typhoid fever. For instance, in August 2023, SK Bioscience, a South Korea-based biotech company, and Vaxxas, an Australia-based biotechnology company that develops a novel needle-free vaccination technology, secured AUD5.4 million ($3.67 million) in funding from Wellcome, a UK-based charity, to develop a typhoid conjugate vaccine that can be delivered by a needle-free patch. This collaboration aims to revolutionize vaccine delivery by developing a novel vaccine-delivery device combination product using Vaxxas' high-density microarray patch (HD-MAP) platform technology with SK Bioscience's proprietary typhoid vaccine.

Regional Outlook For The Global Typhoid VI Polysaccharide Vaccine Market

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2024. The regions covered in the typhoid vi polysaccharide vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the typhoid vi polysaccharide vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Typhoid VI Polysaccharide Vaccine Market?

The typhoid Vi polysaccharide vaccine market consists of sales of Vi capsular polysaccharide vaccine, and non-conjugated Vi polysaccharide vaccine. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Typhoid VI Polysaccharide Vaccine Industry?

The typhoid Vi polysaccharide vaccine market research report is one of a series of new reports from The Business Research Company that provides typhoid Vi polysaccharide vaccine market statistics, including typhoid Vi polysaccharide vaccine industry global market size, regional shares, competitors with typhoid Vi polysaccharide vaccine market share, detailed typhoid Vi polysaccharide vaccine market segments, market trends and opportunities, and any further data you may need to thrive in typhoid Vi polysaccharide vaccine industry. This Typhoid Vi polysaccharide vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Typhoid Vi Polysaccharide Vaccine Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$6.77 billion
Revenue Forecast In 2034	$13.36 billion
Growth Rate	CAGR of 18.5% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Child, Adult 2) By Route Of Administration: Oral, Parenteral 3) By Application: Government Institution, Private Sector, Other Applications Subsegments: 1) By Child: Pediatric Formulations, Age-Specific Dosages 2) By Adult: Standard Adult Formulations, High-Risk Population Formulations
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Sanofi S.A., GlaxoSmithKline PLC, Merck & Co. Inc., Pfizer Inc., Johnson & Johnson Private Limited, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Emergent Biosolutions Inc., PT Bio Farma, Bharat Biotech International Limited, Teva Pharmaceutical Industries Ltd., Novartis AG, Bio-Med Pvt. Ltd., LG Chem, SK Chemicals Co. Ltd., Crucell Switzerland AG, Hualan Biological Engineering Inc., Indian Immunologicals Limited
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Typhoid Vi Polysaccharide Vaccine Market Characteristics

3. Typhoid Vi Polysaccharide Vaccine Market Trends And Strategies

4. Typhoid Vi Polysaccharide Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Typhoid Vi Polysaccharide Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Typhoid Vi Polysaccharide Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Typhoid Vi Polysaccharide Vaccine Market Growth Rate Analysis

5.4. Global Typhoid Vi Polysaccharide Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Typhoid Vi Polysaccharide Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Typhoid Vi Polysaccharide Vaccine Total Addressable Market (TAM)

6. Typhoid Vi Polysaccharide Vaccine Market Segmentation

6.1. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Child

Adult

6.2. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Parenteral

6.3. Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Government Institution

Private Sector

Other Applications

6.4. Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Child, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric Formulations

Age-Specific Dosages

6.5. Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Adult, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Standard Adult Formulations

High-Risk Population Formulations

7. Typhoid Vi Polysaccharide Vaccine Market Regional And Country Analysis

7.1. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market

8.1. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Typhoid Vi Polysaccharide Vaccine Market

9.1. China Typhoid Vi Polysaccharide Vaccine Market Overview

9.2. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Typhoid Vi Polysaccharide Vaccine Market

10.1. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Typhoid Vi Polysaccharide Vaccine Market

11.1. Japan Typhoid Vi Polysaccharide Vaccine Market Overview

11.2. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Typhoid Vi Polysaccharide Vaccine Market

12.1. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Typhoid Vi Polysaccharide Vaccine Market

13.1. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Typhoid Vi Polysaccharide Vaccine Market

14.1. South Korea Typhoid Vi Polysaccharide Vaccine Market Overview

14.2. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Typhoid Vi Polysaccharide Vaccine Market

15.1. Western Europe Typhoid Vi Polysaccharide Vaccine Market Overview

15.2. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Typhoid Vi Polysaccharide Vaccine Market

16.1. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Typhoid Vi Polysaccharide Vaccine Market

17.1. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Typhoid Vi Polysaccharide Vaccine Market

18.1. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Typhoid Vi Polysaccharide Vaccine Market

19.1. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Typhoid Vi Polysaccharide Vaccine Market

20.1. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market

21.1. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market Overview

21.2. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Typhoid Vi Polysaccharide Vaccine Market

22.1. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Typhoid Vi Polysaccharide Vaccine Market

23.1. North America Typhoid Vi Polysaccharide Vaccine Market Overview

23.2. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Typhoid Vi Polysaccharide Vaccine Market

24.1. USA Typhoid Vi Polysaccharide Vaccine Market Overview

24.2. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Typhoid Vi Polysaccharide Vaccine Market

25.1. Canada Typhoid Vi Polysaccharide Vaccine Market Overview

25.2. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Typhoid Vi Polysaccharide Vaccine Market

26.1. South America Typhoid Vi Polysaccharide Vaccine Market Overview

26.2. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Typhoid Vi Polysaccharide Vaccine Market

27.1. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Typhoid Vi Polysaccharide Vaccine Market

28.1. Middle East Typhoid Vi Polysaccharide Vaccine Market Overview

28.2. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Typhoid Vi Polysaccharide Vaccine Market

29.1. Africa Typhoid Vi Polysaccharide Vaccine Market Overview

29.2. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape And Company Profiles

30.1. Typhoid Vi Polysaccharide Vaccine Market Competitive Landscape

30.2. Typhoid Vi Polysaccharide Vaccine Market Company Profiles

30.2.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. GlaxoSmithKline PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Johnson & Johnson Private Limited Overview, Products and Services, Strategy and Financial Analysis

31. Typhoid Vi Polysaccharide Vaccine Market Other Major And Innovative Companies

31.1. AstraZeneca PLC

31.2. Takeda Pharmaceutical Company Limited

31.3. Sun Pharmaceutical Industries Ltd.

31.4. Mallinckrodt Pharmaceuticals

31.5. Emergent Biosolutions Inc.

31.6. PT Bio Farma

31.7. Bharat Biotech International Limited

31.8. Teva Pharmaceutical Industries Ltd.

31.9. Novartis AG

31.10. Bio-Med Pvt. Ltd.

31.11. LG Chem

31.12. SK Chemicals Co. Ltd.

31.13. Crucell Switzerland AG

31.14. Hualan Biological Engineering Inc.

31.15. Indian Immunologicals Limited

32. Global Typhoid Vi Polysaccharide Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Typhoid Vi Polysaccharide Vaccine Market

34. Recent Developments In The Typhoid Vi Polysaccharide Vaccine Market

35. Typhoid Vi Polysaccharide Vaccine Market High Potential Countries, Segments and Strategies

35.1 Typhoid Vi Polysaccharide Vaccine Market In 2029 - Countries Offering Most New Opportunities

35.2 Typhoid Vi Polysaccharide Vaccine Market In 2029 - Segments Offering Most New Opportunities

35.3 Typhoid Vi Polysaccharide Vaccine Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Child, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Adult, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Sanofi S.A. Financial Performance

Table 77: GlaxoSmithKline PLC Financial Performance

Table 78: Merck & Co. Inc. Financial Performance

Table 79: Pfizer Inc. Financial Performance

Table 80: Johnson & Johnson Private Limited Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Child, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Typhoid Vi Polysaccharide Vaccine Market, Sub-Segmentation Of Adult, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Typhoid Vi Polysaccharide Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Route Of Admistration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Typhoid Vi Polysaccharide Vaccine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Sanofi S.A. Financial Performance

Figure 77: GlaxoSmithKline PLC Financial Performance

Figure 78: Merck & Co. Inc. Financial Performance

Figure 79: Pfizer Inc. Financial Performance

Figure 80: Johnson & Johnson Private Limited Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the medical aesthetics market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth

Vaccines Global Market Report 2022 – By Type (Anti-Infective Vaccines, Autoimmunity, Others (Cancer And Others)), By Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines), By Route of Administration (Intramuscular (IM), Subcutaneous (SC), Oral, Others), By Valance (Monovalent, Multivalent), By Distribution Channel (Institutional Sale, Hospital Pharmacies, Retail Pharmacies) – Market Size, Trends, And Global Forecast 2022-2026

View Report

Pediatric Vaccine Global Market Report 2025 – By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate, Other Technologies), By Application (Infectious Disease, Allergy, Cancer) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Cancer Vaccines Global Market Report 2025 – By Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), By Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Whole Cell Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), By Cancer Type (Prostate, Cervical, Colorectal, Throat, Other Cancer Types), By End-User (Cancer Treatment Centers, Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

DTP Vaccines Global Market Report 2025 – By Product type (DTaP, TD, Tdap), By Disease (Diphtheria, Pertussis, Tetanus), By End-User (Hospitals, Clinics, Vaccination Centers) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Veterinary Vaccines Global Market Report 2025 – By Application (Livestock Vaccines, Companion Animal Vaccines), By Vaccine Type (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other Vaccine Types), By Disease Type (Anaplasmosis, Canine Parvovirus, Foot And Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, Porcine Reproductive And Respiratory Syndrome (PRRS)) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Companion Animal Veterinary Vaccines Global Market Report 2025 – By Product (Inactivated, Live Attenuated, Recombinant, Other Products), By Route Of Administration (Oral, Parenteral, Other Routes Of Administration), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies And Drug Stores, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2025 – By Type (Pens, Injectors And Pumps, Syringes), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps), By End Users (Hospitals, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Drug Delivery Devices Global Market Report 2025 – By Route Of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), By Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings), By Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the typhoid Vi polysaccharide vaccine market?

Typhoid VI polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

How will the typhoid Vi polysaccharide vaccine market drivers and restraints affect the typhoid Vi polysaccharide vaccine market dynamics? What forces will shape the typhoid Vi polysaccharide vaccine industry going forward?

The typhoid Vi polysaccharide vaccine market major growth driver - Typhoid VI polysaccharide vaccine refers to the recommendation of active immunization for people aged two and up, concerning the prevention of typhoid fever caused by Salmonella typhi.. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

What is the forecast market size or the forecast market value of the typhoid Vi polysaccharide vaccine market?

The typhoid vi polysaccharide vaccine market size has grown rapidly in recent years. It will grow from $5.78 billion in 2024 to $6.77 billion in 2025 at a compound annual growth rate (CAGR) of 17.1%. The growth in the historic period can be attributed to disease prevalence, global health initiatives, traveler vaccination, government immunization efforts, vaccine efficacy and safety. The typhoid vi polysaccharide vaccine market size is expected to see rapid growth in the next few years. It will grow to $13.36 billion in 2029 at a compound annual growth rate (CAGR) of 18.5%. The growth in the forecast period can be attributed to expanded immunization programs, global health policy focus, epidemiological surveillance, rising demand in travel medicine, environmental and social factors. Major trends in the forecast period include R&D investments, regulatory support, epidemiological studies, public health awareness. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

How is the typhoid Vi polysaccharide vaccine market segmented?

The typhoid Vi polysaccharide vaccine market is segmented
1) By Type: Child, Adult
2) By Route Of Administration: Oral, Parenteral
3) By Application: Government Institution, Private Sector, Other Applications Subsegments:
1) By Child: Pediatric Formulations, Age-Specific Dosages
2) By Adult: Standard Adult Formulations, High-Risk Population FormulationsFor further insights on the typhoid Vi polysaccharide vaccine market, request a sample here

Which region has the largest share of the typhoid Vi polysaccharide vaccine market? What are the other regions covered in the report?

Asia-Pacific was the largest region in the typhoid Vi polysaccharide vaccine market share in 2024. The regions covered in the typhoid vi polysaccharide vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the typhoid Vi polysaccharide vaccine market, request a sample here.

Who are the major players in the typhoid Vi polysaccharide vaccine market?

What are the key trends in the typhoid Vi polysaccharide vaccine market?

Major trend in the typhoid Vi polysaccharide vaccine market - International Vaccine Institute's Dynamic Partnerships With Moderna And GSK Fuel Advances In Typhoid Vi Polysaccharide Vaccine Market. For further insights on the typhoid Vi polysaccharide vacc request a sample here.

What are the major opportunities in the typhoid Vi polysaccharide vaccine market? What are the strategies for the typhoid Vi polysaccharide vaccine market?

For detailed insights on the major opportunities and strategies in the typhoid Vi polysaccharide vaccine market, request a sample here.

How does the typhoid Vi polysaccharide vaccine market relate to the overall economy and other similar markets?

For detailed insights on typhoid Vi polysaccharide vaccine market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the typhoid Vi polysaccharide vaccine industry?

For detailed insights on the mergers and acquisitions in the typhoid Vi polysaccharide vaccine industry, request a sample here.

What are the key dynamics influencing the typhoid Vi polysaccharide vaccine market growth? SWOT analysis of the typhoid Vi polysaccharide vaccine market.

For detailed insights on the key dynamics influencing the typhoid Vi polysaccharide vaccine market growth and SWOT analysis of the typhoid Vi polysaccharide vaccine industry, request a sample here.